• Users Online: 1078
  • Print this page
  • Email this page
Export selected to
Endnote
Reference Manager
Procite
Medlars Format
RefWorks Format
BibTex Format
  Citation statistics : Table of Contents
   2019| January-March  | Volume 2 | Issue 1  
    Online since April 1, 2019

 
 
  Archives   Previous Issue   Next Issue   Most popular articles   Most cited articles
 
Show all abstracts  Show selected abstracts  Export selected to
  Cited Viewed PDF
ORIGINAL ARTICLES
Evidence of calcium-activated potassium channel subunit alpha-1 as a key promoter of glioma growth and tumorigenicity
Divya Khaitan, Nagendra Ningaraj
January-March 2019, 2(1):46-54
DOI:10.4103/glioma.glioma_44_18  
  2 2,938 224
REVIEWS
Combination of oncolytic viruses and immune checkpoint inhibitors in glioblastoma
Kunal Desai, Anne Hubben, Manmeet Ahluwalia
January-March 2019, 2(1):7-19
DOI:10.4103/glioma.glioma_5_19  
  2 6,143 486
Gamma-delta T cells in glioblastoma immunotherapy
Sadhak Sengupta
January-March 2019, 2(1):30-36
DOI:10.4103/glioma.glioma_48_18  
  2 7,178 717
CASE REPORT
Diffuse midline glioma, H3-K27M mutant: Awareness leads to identification
Sadhana Tiwari, Ishita Pant, Sujata Chaturvedi, Gurbachan Singh
January-March 2019, 2(1):55-59
DOI:10.4103/glioma.glioma_1_19  
  1 3,971 283
EDITORIAL
Glioma special issue introduction
Christopher Jackson, Michael Lim
January-March 2019, 2(1):1-2
DOI:10.4103/glioma.glioma_2_19  
  1 3,169 313
ORIGINAL ARTICLES
IDH1 mutation decreases the invasiveness of glioma by downregulating the expression and activity of TAZ
Ningning Li, Rui Zhang, Yi Sun, Chenyue Xu, Yin Wang, Ji Xiong, Qi Chen, Ying Liu
January-March 2019, 2(1):37-45
DOI:10.4103/glioma.glioma_46_18  
  1 2,943 242
REVIEWS
Immune checkpoint modulation: Tenets and implications in glioblastoma
John P Lynes, Victoria E Sanchez, Anthony K Nwankwo, Gifty A Dominah, Edjah K Nduom
January-March 2019, 2(1):20-29
DOI:10.4103/glioma.glioma_47_18  
  - 5,001 360
Importance of iatrogenic immunosuppression in the treatment of patients with high-grade glioma with immunotherapy
Anna F Piotrowski, Stuart A Grossman
January-March 2019, 2(1):3-6
DOI:10.4103/glioma.glioma_8_19  
  - 4,005 297